Advancements in Polymeric Nanocarriers to Mediate Targeted Therapy against Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is a destructive disease with a poor prognosis, low survival rate and high rate of metastasis. It comprises 15% of total breast cancers and is marked by deficiency of three important receptor expressions, i.e., progesterone, estrogen, and human epidermal growth f...

Descripción completa

Detalles Bibliográficos
Autores principales: Fatima, Mahak, Sheikh, Afsana, Abourehab, Mohammed A. S., Kesharwani, Prashant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695386/
https://www.ncbi.nlm.nih.gov/pubmed/36365249
http://dx.doi.org/10.3390/pharmaceutics14112432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695386/
https://www.ncbi.nlm.nih.gov/pubmed/36365249
http://dx.doi.org/10.3390/pharmaceutics14112432

Ejemplares similares